Back to top
more

Integra LifeSciences (IART)

(Delayed Data from NSDQ)

$17.00 USD

17.00
686,509

+0.05 (0.29%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $17.01 +0.01 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Urmimala Biswas headshot

Medical Instruments Outlook Dull Amid Coronavirus Crisis

Many sub domains within the medical instrument space are bearing the brunt of the coronavirus-led prolonged stay-at-home orders.

Integra (IART) Up 8.6% Since Last Earnings Report: Can It Continue?

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Integra (IART) Lags Q1 Earnings Estimates, Withdraws Outlook

Integra's (IART) first-quarter 2020 results reflect disappointing segmental performance due to coronavirus-led business disruptions.

Integra LifeSciences (IART) Misses Q1 Earnings Estimates

Integra (IART) delivered earnings and revenue surprises of -20.00% and 0.46%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Integra LifeSciences (IART) Reports Next Week: What to Know Ahead of the Release

Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain HealthEquity Stock for Now

Investor confidence remains high in HealthEquity (HQY) stock, thanks to solid prospects.

Bio-Rad Launches Serology Test to Detect Coronavirus Antibody

Bio-Rad (BIO) launches a blood-based immunoassay kit to better detect antibodies in response to SARS-CoV-2 infection.

Why Integra (IART) Could Beat Earnings Estimates Again

Integra (IART) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Integra Releases Preliminary Q1 Results, Withdraws '20 View

Integra (IART) unable to measure the magnitude of total loss it has to bear out of the coronavirus-led economic damages, and hence, withdraws the full-year guidance.

Merit Medical WRAPSODY Gets 2 FDA Breakthrough Device Nods

This regulatory clearance is expected to bolster Merit Medical Systems' (MMSI) cardiovascular segment.

Here's Why You Should Retain AMN Healthcare (AMN) for Now

Investor confidence remains high on AMN Healthcare's (AMN) stock, thanks to solid prospects.

Here's Why You Should Add Surmodics to Your Portfolio Now

Investor confidence is high in Surmodics' (SRDX) stock,thanks to solid prospects.

Zacks.com featured highlights include: TGNA, IART, PCG, CLGX and ABC

Zacks.com featured highlights include: TGNA, IART, PCG, CLGX and ABC

Varian Unveils Proton Treatment Planning Eclipse v16 System

The launch of this system is a step forward in Varian's (VAR) commitment toward strengthening its Proton Solutions segment.

Urmimala Biswas headshot

5 Recession-Proof PEG Picks Suitable for GARP Investors

Here are five GARP stocks to brace your portfolio from recessionary hurdles.

Here's Why You Should Add DexCom (DXCM) to Your Portfolio Now

Investor confidence is high in DexCom's (DXCM) stock, thanks to solid prospects.

Syneos Health Launches Initiative for COVID-19 Patients

The primary aim of this initiative by Syneos Health (SYNH) is to address the predicted ventilator deficiency in the wake of the coronavirus pandemic.

IART vs. ABMD: Which Stock Is the Better Value Option?

IART vs. ABMD: Which Stock Is the Better Value Option?

Stellar Codman Surgical Sales Aid Integra Amid Supply Issues

Completion of integration activities, scale expansion, product launches, and venturing into faster-growing markets drive Interga's (IART) sales within Codman Surgical.

Why Is Integra (IART) Down 37.3% Since Last Earnings Report?

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Buy Integra LifeSciences Stock Now

Investor confidence is high in Integra LifeSciences (IART) stock, thanks to solid prospects.

IART vs. ABMD: Which Stock Should Value Investors Buy Now?

IART vs. ABMD: Which Stock Is the Better Value Option?

Integra Launches AmnioExcel Placental Allograft Membrane

The launch of this product is expected to boost Integra's (IART) OTT segment.

Integra LifeSciences Grows Organically Amid Supply Issues

Integra LifeSciences' (IART) Codman Specialty Surgical segment registers impressive organic growth in Q4.

Integra (IART) Q4 Earnings Surpass Estimates, Margins Up

Integra's (IART) fourth-quarter 2019 results reflect strong segmental performances.